Skip to main content
ASTAL LABORATORIES LIMITED logo

ASTAL LABORATORIES LIMITED — Investor Relations & Filings

Ticker · 512600 ISIN · INE307N01014 LEI · 8945004HO2WCBQ0CJ976 BSE.NS Manufacturing
Open in API
Filings indexed 442 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country IN India
Listing BSE.NS 512600

About ASTAL LABORATORIES LIMITED

https://miel.co.in/

Astal Laboratories Limited is a pharmaceutical organization engaged in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations. The company's product portfolio encompasses various dosage forms, including tablets, capsules, liquid orals, and topical preparations. It operates across several therapeutic categories, such as anti-infectives, analgesics, and gastrointestinal treatments. Astal Laboratories prioritizes quality control and adheres to established manufacturing standards to ensure the safety and efficacy of its products. The company focuses on providing accessible healthcare solutions through a robust distribution network and a commitment to research-driven formulation development.

Recent filings

Filing Released Lang Actions
Submission of website intimation.
Regulatory Filings Classification · 95% confidence The document is a short communication addressed to the stock exchange (BSE Limited) under Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the company's official website address and states that the website contains information as required under the regulations. There is no financial data, no detailed report, no management discussion, or any other substantive content typical of financial or regulatory reports. The document is essentially an announcement or intimation to the exchange about compliance-related information. Given the short length (1614 characters) and the nature of the content, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-04-30 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2026-04-27 English
Submission of certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018.
Regulatory Filings Classification · 95% confidence The document is a certificate submitted by the Registrar and Share Transfer Agent under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation 2018 for the quarter ended 31st March 2026. It confirms the dematerialization of securities and related compliance activities. The document is addressed to the stock exchange and is a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data, nor is it an announcement of a report publication. It is a regulatory compliance filing related to securities dematerialization and transfer agent activities. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2026-04-09 English
Submission of Intimation of closure of trading window.
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the stock exchange (BSE Limited) informing about the closure of the trading window for insiders pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. It mentions the upcoming declaration of audited financial results for the quarter ended 31 March 2026 but does not contain any financial data or results itself. The document is short (1986 characters) and serves as an announcement related to compliance and insider trading restrictions rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements that do not fit other specific categories.
2026-03-31 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aceso Research Labs LLP
Regulatory Filings
2026-03-20 English
Submission of Intimation under Regulation 7 (2) of SEBI (PIT) Regulations, 2015.
Regulatory Filings
2026-03-19 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.